ArticleActa dermato-venereologica2021

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study.

Riccardo G Borroni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.